SEC Form 4 · accession 0001179022-17-000001
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore Daniel Zucconi
Director
Period of report
Jan 12, 2017
Accepted (ET)
Jan 20, 2017 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy) | $5.63 | Jan 12, 2017 | S | 2,299 | D | Mar 28, 2012 | Mar 28, 2017 | Common stock | 2,299 | 123 | D |
| Warrants (right to buy) | $5.63 | Jan 13, 2017 | S | 85 | D | Mar 28, 2012 | Mar 28, 2017 | Common stock | 85 | 38 | D |